Articles tagged as 'vaccines'

14 results

Current safety concerns with HPV vaccination
Using adverse event cluster analysis UMC and the Danish pharmacovigilance centre have researched the extent of safety concerns associated with HPV vaccinations.


Countering narratives of distrust key to convincing the vaccine hesitant
Understanding the difference between anti-vaccination belief and vaccine hesitancy is key to setting public health communication strategies, and the stakes have never been higher.


Reflecting on the lessons of a past pandemic – A career comes full circle
At the end of an eventful career, UMC’s retiring chief medical officer, reflects on how the lessons of the H1N1 pandemic helped prepare the pharmacovigilance world for COVID-19.


Keeping vaccines safe – New podcast on COVID-19 vaccine surveillance
UMC experts discuss how real-time vaccine surveillance works during a pandemic and the role of VigiBase in helping to ensure public safety.


Serious errors with two-component vaccines risk harm and damage trust
Medication errors can harm individual patients. But when errors also undermine trust in public health programmes, serious problems can ripple across entire communities.


VigiFlow boosts vaccine surveillance efforts
Multiple COVID-19 vaccines came sooner than expected. But the key systems needed for reporting suspected side effects are up and running to support efficient safety monitoring.


Substandard and Falsified COVID-19 Vaccines in the Americas: Can vaccine equity help?
COVID-19 vaccinations are picking up speed in wealthy countries. But for lower-income countries, does poor equity of access raise the risk of compromised products?


New podcast – More on vaccine equity and S/F vaccines in the Americas
Our latest podcast episode features the audio version of our article on vaccine equity in the Americas, followed by an interview with the author, Danini Marin.


Pharmacovigilance in the age of COVID-19
COVID-19 is one of the most disruptive events in history and a threat to public health. In the rush for treatments and vaccines, how do we keep sight of the need to ensure safety?


Convincing the vaccine hesitant – New Drug Safety Matters podcast
Trust, empathy, and understanding are essential for helping the vaccine hesitant reach the right decisions. But that can be a lot easier said than done.


Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more